The rationale for decision aids is addressed in the accompanying paper. Unlike hormone replacement therapy, prostate surgery is a "Rubicon" procedure -- that is, once undertaken it cannot be reversed. In the United States, a pilot study on the impact of a programme to aid in decisions about benign prostatic hyperplasia showed a 40% decrease in surgery rates. This finding was not replicated in a subsequent randomised controlled trial.
Posted in Patient Decision Aids, Patient Involvement, Special Populations
Tagged Angela Coulter, benign prostatic hyperplasia, BMJ, BPH, decision aids, decision-making, men, multimedia, primary care, prostatectomy, Shared Decision-Making® programs, treatment decisions
Many men face decisions about treatments for an enlarged prostate and the treatment options may cause much confusion. To help men understand their options, the Foundation has developed a Shared Decision-Making® Program called Treatment Choices for Benign Prostatic Hyperplasia.